This page lists the SEC filings reported by ALAFI CAPITAL CO LLC.
Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13D/A | 2019-09-30 | ALAFI CAPITAL CO LLC | Intra-Cellular Therapies, Inc. | 4,673,270 | 8.5% | EDGAR |
SC 13D/A | 2017-10-30 | ALAFI CAPITAL CO LLC | Intra-Cellular Therapies, Inc. | 3,953,270 | 7.2% | EDGAR |
SC 13D/A | 2015-03-24 | ALAFI CAPITAL CO LLC | Intra-Cellular Therapies, Inc. | 3,596,205 | 10.3% | EDGAR |
SC 13D | 2013-09-09 | ALAFI CAPITAL CO LLC | Intra-Cellular Therapies, Inc. | 3,542,885 | 16.0% | EDGAR |
SC 13G/A | 2008-02-14 | ALAFI CAPITAL CO LLC | Stereotaxis, Inc. | 2,842,193 | 7.7% | EDGAR |
SC 13G/A | 2007-02-14 | ALAFI CAPITAL CO LLC | Stereotaxis, Inc. | 2,537,168 | 7.1% | EDGAR |
SC 13G/A | 2006-02-14 | ALAFI CAPITAL CO LLC | Stereotaxis, Inc. | 2,537,169 | 7.7% | EDGAR |
SC 13G/A | 2004-02-13 | ALAFI CAPITAL CO LLC | QIAGEN NV | 7,281,491 | 5.0% | EDGAR |
SC 13G/A | 2003-02-24 | ALAFI CAPITAL CO LLC | QIAGEN NV | 7,505,491 | 5.2% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.